Eli Lilly and Company

CYRAMZA - Cost

Last Updated: April 1st, 2024

HCPCS:

J9308

HCPCS Code Descriptor:

Injection, ramucirumab, 5 mg

Medicare Payment Limit:

The CYRAMZA Medicare Payment Limit is $69.653

Average Sale Price:

CYRAMZA ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The CYRAMZA Medicare Co-insurance percentage is 20%. CYRAMZA's Medicare Co-insurance amount is $13.93 per HCPCS unit.

APC Code:

The Cyramza APC Code is: 1488

APC Payment Limit:

The APC Payment Limit for CYRAMZA is available. Login to view.

Cyramza Cost Information:

CYRAMZA is a product of Eli Lilly and Company and is aligned to HCPCS J9308. CYRAMZA became effective on January 1, 2016. There are two NDCs mapped to J9308. Pricing overall, has increased every year since 2016. ASP remains somewhat apart from WAC indicating a small discount.

ACCESS PRICING AND MORE BY REGISTERING

Cyramza’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Cyramza’s average wholesale price (AWP) information was last updated on:
January 1, 2024

Cyramza Cost Graph: